Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
DMAC — DiaMedica Therapeutics Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 31, 2026
REVENUE
$0
EPS
-$0.17 0.0%
FREE CASH FLOW
-$7.8M -17.4%

No summary has been written for this call yet.